Similarly, the steatosis observed in the patients was phenocopied in hepatocyte models by lipid droplet accumulation and increased lipid droplet–lysosome colocalization, as well as by the observation of hepatic steatosis in our hypomorphic mouse model of TMEM199 deficiency. This evidence concerns the gene VMA12 and fatty liver disease.